Ceftriaxone in the treatment of spontaneous bacterial peritonitis: Ascitic fluid polymorphonuclear count response and short-term prognosis

Hepato-Gastroenterology

Volumn 44, Issue 17, 1997, Pages 1276-1280

  Mesquita, M A ^a   Balbino, E P S ^a   Albuquerque, R S ^a   Carmona, C A ^a   Okubo, B T ^a   Lorena, S L S ^a   Montes, C G ^a   Soares, E C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Ceftriaxone; Cirrhosis; Spontaneous bacterial peritonitis

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASCITES FLUID; BACTERIAL PERITONITIS; BACTERIUM CULTURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; KIDNEY FAILURE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS;

ASCITIC FLUID; BACTERIAL INFECTIONS; CEFTRIAXONE; CELL COUNT; CEPHALOSPORINS; FEMALE; HOSPITAL MORTALITY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEUTROPHILS; PERITONITIS; PROGNOSIS; TIME FACTORS;

EID: 0030881484     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hoefs JC, Runyon BA. Spontaneous bacterial peritonitis. Dis month 1985; 31: 1-48.
2. Andreu M, Sola R, Sitges-Serra A, Alia C, Gallenn M, Vila MC, Coll S, Oliver MI. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 1993; 104: 1133-1138.
3. Mihas AA, Toussaint J, Hsu HS, Dotherow P, Achord JL. Spontaneous bacterial peritonitis in cirrhosis: clinical and laboratory features, survival and prognostic indicators. Hepato-Gastroenterol 1992; 39; 520-522.
4. Llovet JM, Planas R, Morillas R, Quer JC, Cabré E, Boix J, Humbert P, Guilera M, Doménech E, Bertrán X, Gassul MA. Short-term prognosis of cirrhotic with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol 1993; 88: 388-392.
5. Felisart J, Rimola A, Arroyo V, Pérez-Ayuso RM, Quintero E, Ginés P, Rodés J. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotic with severe infections. Hepatology 1985; 5: 457-462.
6. Toledo C, Salmerón JM, Rimola A, Navasa M, Arroyo V, Llach J, Ginès A, Ginés P, Rodés J. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993; 17: 251-257.
7. Rimola A, Navasa M, Arroyo V. Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis. Diagn Microbiol Inf Dis 1995; 22: 141-145.
8. Gomez-Jimenez J, Ribera E, Gasser I, Artaza MA, Del-Valle O, Pahissa A, Martinez-Vazquez JM. Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob Agents Chemother 1993; 37: 1587-1592.
9. Fong Tse-L, Akriviadis EA, Runyon BA, Reynolds TB. Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis. Hepatology 1989; 9: 423-426.
10. Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988; 95: 1351-1355.
11. Brown RA, Beck JS. Medical Statistics on Microcomputers. London: Latimer Trend and Company Ltd 1990; 29-47.
12. Rimola A, Salmerón JM, Clemente G, Rodrigo L, Obrador A, Miranda ML, Guarner C, et al. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 1995; 21: 674-679.
13. Pelletier G, Salmon D, Ink O, Hannoun S, Attali P, Buffet C, Etienne JP. Culture-negative neutrocytic ascites: a less severe variant of spontaneous bacterial peritonitis. J Hepatol 1990; 10: 327-331.
14. Terg R, Levi D, Lopez P, Rafaelli C, Rojter S, Abecasis R, Villamil F, Aziz H, Podesta A. Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis and neutrocytic ascites. Evidence of the same disease. Dig Dis Sci 1992; 37: 1499-1504.
15. Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988; 8: 632-635.
16. Llach J, Rimola A, Navasa M, Ginès P, Salmerón JM, Ginès A, Arroyo V, Rodés J. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 1992; 16: 724-727.
17. Runyon BA, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA. Short-course versus long-course antibiotic treatment for spontaneous bacterial peritonitis: a randomized controlled study of 100 patients. Gastroenterology 1991; 100: 1737-1742.
18. Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, Gassull MA, Arroyo V, Rodés J. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994; 20: 1495-1501.